Fulvestrant
NDC 68462-317, Fulvestrant, injection, from GLENMARK PHARMACEUTICALS INC., USA.
- Product NDC
- 68462-317
- Status
- Listed
- Labeler
- GLENMARK PHARMACEUTICALS INC., USA
- Dosage form
- INJECTION
- Route
- INTRAMUSCULAR
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA207754
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/68462-317 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- FULVESTRANT50 mg/mL
Pharmacologic classes
Estrogen Receptor Antagonist [EPC]; Estrogen Receptor Antagonists [MoA]; Selective Estrogen Receptor Modulators [MoA]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 68462-317-32 | 68462031732 | 2 SYRINGE, GLASS in 1 CARTON (68462-317-32) / 5 mL in 1 SYRINGE, GLASS (68462-317-40) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/99cf8b69-4c23-4886-80e9-b23e348b5bd7Medicare Part B payment limits (ASP)
GET /v1/drugs/asp?ndc=68462-317
Use it
Look up 68462-317 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/68462-317 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 68462-317. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.